| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $10.42M | - | |
| CFO | 158.7K | $7.14M | - | |
| VP | 111.5K | $5.02M | - | |
| COO | 27.9K | $1.26M | - | |
| Dir | 25.7K | $1.16M | -2,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Wright Christopher I | Director | Sell | 2,000 | $45.10 | $90,200.00 | -7.2% | - | - | |
| Jun 1, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $41.67 | $375,043.50 | -10.4% | - | - | |
| May 29, 2026 | Parisi Samuel Joseph62 | VP, Finance (interim Pao) | Sale+OE | 16,217 | $42.36 | $687,007.26 | -67.8% | - | - | |
| May 1, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $33.40 | $300,559.50 | -10.0% | - | - | |
| Feb 2, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 9,000 | $33.93 | $305,384.50 | -7.0% | -4.5% | - | |
| Feb 2, 2026 | Cooke Shane62 | Director | Sale+OE | 61,200 | $34.57 | $2,115,672.52 | -20.3% | -4.5% | - | |
| Jan 8, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 5,000 | $30.00 | $150,005.00 | -7.5% | +17.5% | - | |
| Jan 2, 2026 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 4,000 | $28.00 | $112,000.00 | -6.1% | +23.3% | - | |
| Dec 3, 2025 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 3,748 | $30.00 | $112,447.12 | -5.4% | -1.1% | - | |
| Dec 1, 2025 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 4,000 | $29.30 | $117,200.00 | -5.7% | +4.6% | - |